Becton Dickinson & Co.

BDX

$266.77

+13.0% last 12 months

Al Gore Holding value: $507 Million First Eagle Investments Holding value: $471 Million Ken Griffin Holding value: $371 Million Ray Dalio Holding value: $87.8 Million Jim Simons Holding value: $9.01 Million Mario Gabelli Holding value: $2.82 Million Jefferies Group Holding value: $448 Thousand Ken Fisher Holding value: $394 Thousand Joel Greenblatt Holding value: $226 Thousand Richard Pzena Holding value: $0 Andreas Halvorsen Holding value: $0 Steven Cohen Holding value: $0 Terry Smith Holding value: $0 Jeremy Grantham Holding value: $0 Chuck Akre Holding value: $0 Tom Gayner Holding value: $0 Tom Russo Holding value: $0 David Einhorn Holding value: $0 Chris Davis Holding value: $0 George Soros Holding value: $0 Donald Yacktman Holding value: $0 David Tepper Holding value: $0 Warren Buffett Holding value: $0

Market Cap

$68.7 Billion

The market capitalization is the market value of the company. It is the sum of the value of all outstanding shares.

52 Week Range

$212.77 - $286.34

The lowest and highest price in the last 52 weeks.

Price-Earnings Ratio

48.57x

The price-earnings ratio is the ratio between the price per share (stock price) and the earnings per share. It indicates the percentage of the price per share (stock price) that is generated in earnings in the last 12 months.

Dividends per Share

$3.62 (1.37%)

Dividends per share is the amount of dividends paid out to the shareholder of a single share in the last 12 months. The percentage indicates the ratio of the company's annual dividend compared to its current price per share (stock price).

Revenue & Earnings

Balance Sheet

Share Statistics

Compare to
Market
Industry
Market Cap The market value of the company. It's calculated by multiplying the share price by the number of outstanding shares. $68.7 Billion
Enterprise Value A measure of a company's total value. This includes market cap, cash, and debt. $84.5 Billion
Dividend Yield Yearly payout to shareholders per share. The percentage indicates the payout in relation to the share price. $3.62 (1.37%)
1 Year Return Profit or loss of share price change plus dividend yield. +14.4%
52-Week High Highest share price in the last 52 weeks. $286.34
52-Week Low Lowest share price in the last 52 weeks. $212.77
Beta Beta indicates the volatility of a stock compared to the market. Higher beta means more volatile and thus potentially higher risk and return. 0.66
Outstanding Shares The number of shares the company has issued and are held by stockholders. 290 Million
Avg 30 Day Volume The number of shares traded in the last 30 days. 1.21 Million

Valuation

Compare to
Market
Industry
P/E Ratio Ratio between share price and earnings per share. A low ratio could indicate that the stock is undervalued or investors aren't expecting high growth. A high ratio could indicate that the stock is overvalued or investors are expecting high growth. 48.57
PEG The ratio between the P/E ratio and the growth rate of the company's earnings per share in the last twelve months. A lower PEG could mean that a stock is undervalued. 304.03
Earnings per Share Earnings divided by outstanding shares. Higher EPS indicates greater value. $5.52
Price to Sales Ratio Market cap divided by the revenue in the most recent year. 4.23
Price to Book Ratio Price to Book Ratio is the Market cap divided by the Book value of the company 3.0
Enterprise Value to Revenue Enterprise value divided by revenue 4.57
Enterprise Value to EBIT Enterprise Value divided by EBIT 36.29
Total Debt to Enterprise Value Total debt divided by enterprise value 0.2
Debt to Equity A higher ratio indicates a higher risk. However, the ratio is difficult to compare between industries where common amounts of debt vary. 0.65

Profitability

Compare to
Market
Industry
Revenue Revenue is the sum of all cash flow into the company. $18.5 Billion
Gross Profit Gross profit is the profit after subtracting the costs of making and selling its products or the costs of providing its services. It indicates the efficiency of using their resources to produce goods or services. $8.15 Billion
EBIT Earnings before tax and interest payments. $2.33 Billion
Net Income Net Income is the profit after all expenses have been deducted from the total revenue. $1.58 Billion
Profit Margin Net income divided by revenue of the last 4 quarters. It indicates the company's profitability. 8.55%
Quarterly Earnings Growth (YoY) The rate at which the company's net income has increased to the same quarter one year ago. +16.0%
Return on Equity Equity divided by market cap. 6.10%
Return on Assets Indicates a company's profitability in relation to its total assets. 2.99%
Return on Invested Capital Return on invested capital (ROIC) is net income after dividends divided by the sum of debt and equity. It shows how effective a company is at turning capital invested by shareholders and other debtholders into profits. 5.05%

Insider trades

No purchases

No sells

No purchases

No sells

No purchases

No sells

No purchases

No sells

Q4 2022 Q1 2023 Q2 2023 Q3 2023

About Becton Dickinson & Co.

CEO: Thomas Polen

Employees: 72,000

Industry: Surgical and Medical Instrument Manufacturing

BD is one of the largest global medical technology companies in the world and is advancing the world of health by improving medical discovery, diagnostics and the delivery of care. The company supports the heroes on the frontlines of health care by developing innovative technology, services and solutions that help advance both clinical therapy for patients and clinical process for health care providers. BD and its 65,000 employees have a passion and commitment to help enhance the safety and efficiency of clinicians' care delivery process, enable laboratory scientists to accurately detect disease and advance researchers' capabilities to develop the next generation of diagnostics and therapeutics. BD has a presence in virtually every country and partners with organizations around the world to address some of the most challenging global health issues. By working in close collaboration with customers, BD can help enhance outcomes, lower costs, increase efficiencies, improve safety and expand access to health care.

Similar stocks

Thermo Fisher Scientific Inc.
Thermo Fisher Scientific Inc.
DENTSPLY Sirona Inc
DENTSPLY Sirona Inc
Intuitive Surgical Inc
Intuitive Surgical Inc
Hologic, Inc.
Hologic, Inc.
Baxter International Inc.
Baxter International Inc.
Resmed Inc.
Resmed Inc.
Teleflex Incorporated
Teleflex Incorporated
Varian Medical Systems, Inc.
Varian Medical Systems, Inc.
Harvard Bioscience Inc.
Harvard Bioscience Inc.
Bio-Rad Laboratories Inc. - Class A
Bio-Rad Laboratories Inc. - Class A

News

Nordea Investment Management AB Cuts Stock Position in Becton, Dickinson and Company (NYSE:BDX)

Nordea Investment Management AB Cuts Stock Position in Becton, Dickinson and Company (NYSE:BDX)

Nordea Investment Management AB lowered its holdings in Becton, Dickinson and Company (NYSE:BDX – Free Report) by 2.8% during the 2nd quarter, according to t...

The AM Reporter The AM Reporter, 10 days ago
Deep Dive Into Becton Dickinson & Co''s Dividend Performance

Deep Dive Into Becton Dickinson & Co''s Dividend Performance

Deep Dive Into Becton Dickinson & Co''s Dividend Performance

GuruFocus GuruFocus, 19 days ago
Looking Into Becton, Dickinson''s Recent Short Interest

Looking Into Becton, Dickinson''s Recent Short Interest

Becton, Dickinson''s (NYSE: BDX ) short percent of float has risen 12.5% since its last report. The company recently reported that it has 2.31 million shares...

Benzinga Benzinga, about 2 months ago
Barclays maintains Becton Dickinson at ''overweight'' with a price target of $303.00

Barclays maintains Becton Dickinson at ''overweight'' with a price target of $303.00

https://www.investing.com/news/pro/becton-dickinsn-receives-investment-bank-analyst-rating-update-3146329

Investing.com Investing.com, about 2 months ago
Never miss a trade
To improve your user experience we use cookies.